How regulatory T cells work

Nature Reviews Immunology

Volumn 8, Issue 7, 2008, Pages 523-532

  Vignali, Dario A A ^a   Collison, Lauren W ^a   Workman, Creg J ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GRANZYME; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 21; INTERLEUKIN 23; INTERLEUKIN 35; INTERLEUKIN 6; PERFORIN; RETINOIC ACID RECEPTOR; STAT3 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ALLERGIC ENCEPHALOMYELITIS; ASTHMA; AUTOIMMUNE DISEASE; CELL TYPE; CELLULAR IMMUNITY; CHRONIC DISEASE; CYTOKINE PRODUCTION; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; EFFECTOR CELL; ENTERITIS; HELPER CELL; HEPATITIS B VIRUS; HUMAN; IMMUNE DYSREGULATION; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; INFLAMMATORY DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; IPEX SYNDROME; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TUMOR IMMUNITY;

ANIMALS; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; FORKHEAD TRANSCRIPTION FACTORS; GRANZYMES; HUMANS; PERFORIN; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 46249101518     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri2343     Document Type: Review

References (128)

1. + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 182, 18-32 (2001).
2. + regulatory T cells. Immunol. Rev. 212, 60-73 (2006).
3. Xystrakis, E., Boswell, S. E. & Hawrylowicz, C. M. T regulatory cells and the control of allergic disease. Expert. Opin. Biol. Ther. 6, 121-133 (2006).
4. Coombes, J. L., Robinson, N. J., Maloy, K. J., Uhlig, H. H. & Powrie, F. Regulatory T cells and intestinal homeostasis. Immunol. Rev. 204, 184-194 (2005).
5. Belkaid, Y. Regulatory T cells and infection: a dangerous necessity. Nature Rev. Immunol. 7, 875-888 (2007).
6. Rouse, B. T., Sarangi, P. P. & Suvas, S. Regulatory T cells in virus infections. Immunol. Rev. 212, 272-286 (2006).
7. Kretschmer, K., Apostolou, I., Jaeckel, E., Khazaie, K. & von Boehmer, H. Making regulatory T cells with defined antigen specificity: role in autoimmunity and cancer. Immunol. Rev. 212, 163-169 (2006).
8. Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061 (2003).
9. Reg-cell development and is sufficient to confer regulatory activity on naive T cells.
10. Bennett, C. L. et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nature Genet. 27, 20-21 (2001).
11. Wildin, R. S. et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nature Genet. 27, 18-20 (2001).
12. Brunkow, M. E. et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nature Genet. 27, 68-73 (2001). References 10-12 were the first to identify FOXP3 as the defective gene in patients with IPEX and in scurfy mice.
13. Rudensky, A. Foxp3 and dominant tolerance. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 360, 1645-1646 (2005).
14. Ramsdell, F. Foxp3 and natural regulatory T cells: key to a cell lineage? Immunity 19, 165-168 (2003).
15. Hill, J. A. et al. Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity 27, 786-800 (2007).
16. Allan, S. E. et al. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int. Immunol. 19, 345-354 (2007).
17. + T regulatory cells in humans. Hum. Immunol. 66, 13-20 (2005).
18. + T cells. Eur. J. Immunol. 37, 129-138 (2007).
19. Gavin, M. A. et al. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc. Natl Acad. Sci. USA 103, 6659-6664 (2006).
20. +FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-β-dependent but does not confer a regulatory phenotype. Blood 110, 2983-2990 (2007).
21. Vignali, D. How many mechanisms do regulatory T cells need? Eur. J. Immunol. 38, 908-911 (2008).
22. + regulatory T cell: a jack of all trades, master of regulation. Nature Immunol. 9, 239-244 (2008).
23. + T-cell population had regulatory activity.
24. Shevach, E. M. From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity 25, 195-201 (2006).
25. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10, 1969-1980 (1998).
26. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188, 287-296 (1998).
27. + T cells with regulatory properties from human blood. J. Exp. Med. 193, 1303-1310 (2001).
28. + T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193, 1285-1294 (2001).
29. Hawrylowicz, C. M. & O'Garra, A. Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nature Rev. Immunol. 5, 271-283 (2005).
30. Annacker, O., Asseman, C., Read, S. & Powrie, F. Interleukin-10 in the regulation of T cell-induced colitis. J. Autoimmun. 20, 277-279 (2003).
31. + T cell regulation of airway allergic responses depends on IL-10 induction of TGF-β. J. Immunol. 178, 1433-1442 (2007).
32. Reg cells.
33. Rubtsov, Y. P. et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28, 546-558 (2008).
34. Stoop, J. N. et al. Tumor necrosis factor ? inhibits the suppressive effect of regulatory T cells on the hepatitis B virus-specific immune response. Hepatology 46, 699-705 (2007).
35. + T regulatory cells: relevance to mechanism of heart allograft tolerance. J. Immunol. 179, 6749-6761 (2007).
36. Kursar, M. et al. Cutting Edge: regulatory T cells prevent efficient clearance of Mycobacterium tuberculosis. J. Immunol. 178, 2661-2665 (2007).
37. - Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J. Exp. Med. 204, 273-283 (2007).
38. - Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J. Exp. Med. 204, 285-297 (2007).
39. Beiting, D. P. et al. Coordinated control of immunity to muscle stage Trichinella spiralis by IL-10, regulatory T cells, and TGF-β. J. Immunol. 178, 1039-1047 (2007).
40. Reg cells require IL-10 for their maximal regulatory activity.
41. Bergmann, C., Strauss, L., Zeidler, R., Lang, S. & Whiteside, T. L. Expansion and characteristics of human T regulatory type 1 cells in co-cultures simulating tumor microenvironment. Cancer Immunol. Immunother. 56, 1429-1442 (2007).
42. Loser, K. et al. IL-10 controls ultraviolet-induced carcinogenesis in mice. J. Immunol. 179, 365-371 (2007).
43. Erhardt, A., Biburger, M., Papadopoulos, T. & Tiegs, G. IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice. Hepatology 45, 475-485 (2007).
44. Ivars, F. T cell subset-specific expression of antigen receptor β chains in ? chain-transgenic mice. Eur. J. Immunol. 22, 635-639 (1992).
45. Schumacher, A. et al. Mechanisms of action of regulatory T cells specific for paternal antigens during pregnancy. Obstet. Gynecol. 110, 1137-1145 (2007).
46. + T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis. J. Immunol. 178, 3447-3456 (2007).
47. + regulatory T cells can mediate suppressor function in the absence of transforming growth factor β1 production and responsiveness. J. Exp. Med. 196, 237-246 (2002).
48. Reg cells require cell-surface-bound TGFβ for their maximal regulatory activity.
49. + T cells through TGF-β-TGF-β receptor interactions in type 1 diabetes. Proc. Natl Acad. Sci. USA 100, 10878-10883 (2003).
50. + regulatory T cells. J. Exp. Med. 201, 737-746 (2005).
51. Li, M. O., Wan, Y. Y. & Flavell, R. A. T cell-produced transforming growth factor-β1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity 26, 579-591 (2007).
52. + T cells secreting interleukin-10 and transforming growth factor-β1 mediates suppression in the tumor microenvironment. Clin. Cancer Res. 13, 4345-4354 (2007).
53. +. J. Immunol. 178, 4051-4061 (2007).
54. + regulatory T cells decreased the antitumor activity of cytokine-induced killer (CIK) cells of lung cancer patients. J. Clin. Immunol. 27, 317-326 (2007).
55. Clayton, A., Mitchell, J. P., Court, J., Mason, M. D. & Tabi, Z. Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2. Cancer Res. 67, 7458-7466 (2007).
56. Xia, Z. W. et al. Heme oxygenase-1 attenuates ovalbumin-induced airway inflammation by upregulation of Foxp3 T-regulatory cells, interleukin-10, and membrane-bound transforming growth factor-β1. Am. J. Pathol. 171, 1904-1914 (2007).
57. Ostroukhova, M. et al. Treg-mediated immunosuppression involves activation of the Notch-HES1 axis by membrane-bound TGF-β. J. Clin. Invest. 116, 996-1004 (2006).
58. Reg-cell maximal regulatory activity.
59. Gavin, M. A. et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445, 771-775 (2007).
60. Lieberman, J. The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal. Nature Rev. Immunol. 3, 361-370 (2003).
61. Grossman, W. J. et al. Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood 104, 2840-2848 (2004).
62. + immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16, 311-323 (2002).
63. + T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion. J. Exp. Med. 199, 1479-1489 (2004).
64. Reg cells was required for their regulatory activity in vivo.
65. + T cells selectively kill B lymphocytes. Blood 107, 3925-3932 (2006).
66. Cao, X. et al. Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance. Immunity 27, 635-646 (2007).
67. + regulatory T cells. Cell Death. Differ. 14, 2076-2084 (2007).
68. + T cells. Blood 109, 2058-2065 (2007).
69. + regulatory T cell function. Eur. J. Immunol. 34, 2480-2488 (2004).
70. Fontenot, J. D., Rasmussen, J. P., Gavin, M. A. & Rudensky, A. Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nature Immunol. 6, 1142-1151 (2005).
71. + T lymphocytes. J. Immunol. 174, 155-163 (2005).
72. + T cells. Nature Immunol. 8, 1353-1362 (2007).
73. + regulatory T cells: independence of IL-2 consumption, TGF-β, and various inhibitors of TCR signaling. J. Immunol. 179, 3578-3587 (2007).
74. Deaglio, S. et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204, 1257-1265 (2007).
75. + Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 110, 1225-1232 (2007).
76. Reg cells to generate the inhibitory molecule adenosine by selective expression of CD39 and CD73. Reference 79 showed that another inhibitory adenosine nucleoside, cAMP, is directly transferred into effector T cells via gap junctions.
77. Zarek, P. E. et al. A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. Blood 111, 251-259 (2008).
78. Oukka, M. Interplay between pathogenic Th17 and regulatory T cells. Ann. Rheum. Dis. 66 (Suppl 3), 87-90 (2007).
79. Bopp, T. et al. Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J. Exp. Med. 204, 1303-1310 (2007).
80. + regulatory T cells control autoimmunity? Curr. Opin. Immunol. 17, 638-642 (2005).
81. Tang, Q. et al. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nature Immunol. 7, 83-92 (2006).
82. Reg-cell-DC interactions as a mechanism for blocking effector-T-cell activation.
83. Reg cells require CTLA4 for their maximal regulatory activity in vivo.
84. + regulatory T-cell-mediated suppression. Immunology 118, 240-249 (2006).
85. + T cells. Immunity 19, 877-889 (2003).
86. Reg cells initiate the IDO-mediated catabolism of tryptophan in a CTLA4-dependent manner.
87. Mellor, A. L. & Munn, D. H. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nature Rev. Immunol. 4, 762-774 (2004).
88. + regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur. J. Immunol. 30, 1538-1543 (2000).
89. Kryczek, I. et al. Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells. J. Immunol. 177, 40-44 (2006).
90. + T cells protect against experimentally induced asthma and alter pulmonary dendritic cell phenotype and function. J. Exp. Med. 202, 1549-1561 (2005).
91. high regulatory T cells modulate myeloid but not plasmacytoid dendritic cells activation. J. Immunol. 176, 5293-5298 (2006).
92. + T cells restrain the maturation and antigen-presenting function of dendritic cells. J. Immunol. 172, 4676-4680 (2004).
93. + regulatory T cells. Hum. Immunol. 66, 222-230 (2005).
94. + regulatory T cells induce alternative activation of human monocytes/macrophages. Proc. Natl Acad. Sci. USA 104, 19446-19451 (2007).
95. Workman, C. J. & Vignali, D. A. A. Negative regulation of T cell homeostasis by LAG-3 (CD223). J. Immunol. 174, 688-695 (2004).
96. Huang, C. T. et al. Role of LAG-3 in regulatory T cells. Immunity 21, 503-513 (2004).
97. Liang, B. et al. Regulatory T cells inhibit dendritic cells by LAG-3 engagement of MHC class II. J. Immunol. 180, 5916-5926 (2008).
98. Baecher-Allan, C., Wolf, E. & Hafler, D. A. MHC class II expression identifies functionally distinct human regulatory T cells. J. Immunol. 176, 4622-4631 (2006).
99. Sarris, M., Andersen, K. G., Randow, F., Mayr, L. & Betz, A. G. Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition. Immunity 28, 402-413 (2008).
100. Lu, L. F. et al. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 442, 997-1002 (2006).
101. Kaplan, D. Autocrine secretion and the physiological concentration of cytokines. Immunol. Today 17, 303-304 (1996).
102. + T-cell subset. Blood 105, 2877-2886 (2005).
103. Baecher-Allan, C., Wolf, E. & Hafler, D. A. MHC class II expression identifies functionally distinct human regulatory T cells. J. Immunol. 176, 4622-4631 (2006).
104. + T cell suppressor function. J. Immunol. 172, 6519-6523 (2004).
105. Kim, J. M., Rasmussen, J. P. & Rudensky, A. Y. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nature Immunol. 8, 191-197 (2007).
106. Fontenot, J. D. et al. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22, 329-341 (2005).
107. + T cells. Cell. Mol. Immunol. 3, 189-195 (2006).
108. Seddiki, N. et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 203, 1693-1700 (2006).
109. Reg cells. J. Exp. Med. 203, 1701-1711 (2006).
110. Yamaguchi, T. et al. Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor. Immunity 27, 145-159 (2007).
111. Fontenot, J. D., Dooley, J. L., Farr, A. G. & Rudensky, A. Y. Developmental regulation of Foxp3 expression during ontogeny. J. Exp. Med. 202, 901-906 (2005).
112. + T cell receptors. Immunity 21, 267-277 (2004).
113. Izcue, A., Coombes, J. L. & Powrie, F. Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol. Rev. 212, 256-271 (2006).
114. Roncarolo, M. G. et al. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 212, 28-50 (2006).
115. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198, 1875-1886 (2003).
116. Mucida, D. et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317, 256-260 (2007).
117. + regulatory T cells via a TGF-β and retinoic acid-dependent mechanism. J. Exp. Med. 204, 1757-1764 (2007).
118. Sun, C. M. et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204, 1775-1785 (2007).
119. Benson, M. J., Pino-Lagos, K., Rosemblatt, M. & Noelle, R. J. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J. Exp. Med. 204, 1765-1774 (2007).
120. Schambach, F., Schupp, M., Lazar, M. A. & Reiner, S. L. Activation of retinoic acid receptor-α favours regulatory T cell induction at the expense of IL-17-secreting T helper cell differentiation. Eur. J. Immunol. 37, 2396-2399 (2007).
121. + regulatory T cells. J. Immunol. 179, 3724-3733 (2007).
122. 8 on dendritic cells causes autoimmunity and colitis in mice. Nature 449, 361-365 (2007).
123. Matsumura, Y. et al. Selective expansion of Foxp3-positive regulatory T cells and immunosuppression by suppressors of cytokine signaling 3-deficient dendritic cells. J. Immunol. 179, 2170-2179 (2007).
124. + T cell subsets. J. Leukoc. Biol. 82, 335-346 (2007).
125. + regulatory T cells. Proc. Natl Acad. Sci. USA 104, 18169-18174 (2007).
126. Grossman, W. J. et al. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 21, 589-601 (2004).
127. Bluestone, J. A. & Abbas, A. K. Natural versus adaptive regulatory T cells. Nature Rev. Immunol. 3, 253-257 (2003).
128. + T regulatory cells: role of tumor-derived TGF-β. J. Immunol. 178, 2883-2892 (2007).